Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp has demonstrated a positive trajectory, with organic sales increasing by 5%, reflecting robust growth across its varied product offerings. Notably, the healthcare segment has shown remarkable performance, achieving double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Furthermore, four out of nine key end markets, representing 40% of Avient's sales, are experiencing growth this year, indicating a diverse and resilient revenue base despite anticipated challenges in certain markets.

Avient Corporation has experienced an overall decline in organic sales, with a notable drop of approximately 2% in the first quarter of 2024, despite some rebound in subsequent quarters. The company faces a concerning trend of weakening demand in the chemicals sector since mid-2025, with projections indicating potential downside risks to volume in the second half of 2025. Additionally, although a decline in the dollar may offer some short-term benefits, the ongoing issues in sales performance and demand suggest significant challenges ahead for Avient's financial outlook.